Peritoneal autoantibody profiling identifies p53 as an autoantibody target in endometriosis

被引:2
作者
Harden, Sarah [1 ,2 ,3 ]
Tan, Tse Yeun [4 ,5 ]
Ku, Chee Wai [4 ,5 ]
Zhou, Jieliang
Chen, Qingfeng [3 ]
Chan, Jerry Kok Yen [4 ,5 ]
Brosens, Jan [2 ,7 ,8 ]
Lee, Yie Hou [1 ,5 ,6 ,9 ,10 ]
机构
[1] Singapore MIT Alliance Res & Technol, Crit Analyt Mfg Precis Med, Singapore, Singapore
[2] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Clin Sci Res Labs, Coventry, England
[3] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore
[4] KKH, Dept Reprod Med, Singapore, Singapore
[5] Duke NUS Med Sch, Acad Clin Program, OBGYN, Singapore, Singapore
[6] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore
[7] Univ Hosp Coventry & Warwickshire, Tommys Natl Ctr Miscarriage Res, Coventry, England
[8] Univ Warwick, Ctr Early Life, Warwick Med Sch, Coventry, England
[9] Singhealth Duke NUS Acad Med, OBGYN ACP, 100 Bukit Timah Rd, Singapore 229899, Singapore
[10] Singapore MIT Alliance Res & Technol, 1 CREATE Way,04-13-14 Enterprise Wing, Singapore 138602, Singapore
基金
英国惠康基金; 英国医学研究理事会;
关键词
Endometriosis; autoantibodies; autoimmunity; peritoneal; p53; TUMOR-SUPPRESSOR; AUTOIMMUNE; WOMEN; ANTIBODIES; EXPRESSION; OVARIAN; CANCER; OVEREXPRESSION; CITRULLINATION; GLYCOPROTEIN;
D O I
10.1016/j.fertnstert.2023.02.025
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To map the peritoneal autoantibody (AAb) landscape in women with endometriosis.Design: Case-control laboratory study. Setting: Academic medical and research units.Patient(s): Women who presented with or without endometriosis. Intervention(s): None.Main Outcome Measure(s): Using native-conformation and citrullinated modified protein arrays, proteome-wide analysis of AAbs against 1,623 proteins were profiled in peritoneal fluids (PFs) of 25 women with endometriosis and 25 women without endometriosis.Result(s): In women with endometriosis, the median number of AAbs detected was 4, including AAbs that targeted autoantigens involved in implantation, B-cell activation/development, and aberrant migration and mitogenicity. Forty-six percent of women with endometriosis have R5 peritoneal AAbs. Conversely, in women without endometriosis, the median number of detected AAbs was 1. Autoantibodies recognizing tumor suppressor protein p53 were the most commonly detected AAbs, being present in 35% of women with endometriosis, and p53 AAb was associated with a monocyte/macrophage-like PF cytokine signature. Further investigation of the global reactivity of AAbs against citrullinated PF antigens by peptidylarginine deiminase enzymes 1, 2, and 6 revealed anticitrullinated p53 as the only AAb target elevated and citrullinated by all 3 peptidylarginine deiminase isotypes. Furthermore, unsupervised hierarchical clustering and integrative pathway analysis revealed that 60% of women with endometriosis-associated infertility were positive for AAbs, which are involved in platelet-derived growth factor, transforming growth factor -b, RAC1/PAK1/ p38/MMP2 signaling, LAT2/NTAL/LAB-mediated calcium mobilization, and integrin-mediated cell adhesion.Conclusion(s): Together, our data identify peritoneal autoimmunity in a significant subset of women with endometriosis, with impli-cations on infertility and disease pathophysiology. In these patients, p53 was identified as the most frequent PF AAb target, which was present in both the native and citrullinated forms. (Fertil Steril & REG; 2023;120:176-87. & COPY;2023 by American Society for Reproductive Med-icine.) El resumen esta disponible en Espanol al final del articulo.
引用
收藏
页码:176 / 187
页数:12
相关论文
共 50 条
  • [41] A Meta-analysis of the Association between p53 Codon 72 Polymorphism and Susceptibility to Endometriosis
    Song, Gwan Gyu
    Lee, Young Ho
    IMMUNOLOGICAL INVESTIGATIONS, 2014, 43 (06) : 595 - 605
  • [42] Detection and Quantification of Tp53 and p53-Anti-p53 Autoantibody Immune Complex: Promising Biomarkers in Early Stage Lung Cancer Diagnosis
    Song, Keum-Soo
    Nimse, Satish Balasaheb
    Warkad, Shrikant Dashrath
    Kim, Jung-Hoon
    Kim, Hey-Jin
    Kim, Taisun
    BIOSENSORS-BASEL, 2022, 12 (02):
  • [43] Anti-p53 Autoantibody Detection in Automatic Glass Capillary Immunoassay Platform for Screening of Oral Cavity Squamous Cell Carcinoma
    Lin, Yen-Heng
    Wu, Chih-Ching
    Chen, Wan-Ling
    Chang, Kai-Ping
    SENSORS, 2020, 20 (04)
  • [44] p53 as a biomarker and potential target in gastrointestinal stromal tumors
    Wu, Chiao-En
    Chen, Chiao-Ping
    Huang, Wen-Kuan
    Pan, Yi-Ru
    Aptullahoglu, Erhan
    Yeh, Chun-Nan
    Lunec, John
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Polymorphism at Codon 72 of the p53 Gene Is Not Associated With Endometriosis in a Japanese Population
    Shinya Omori
    Shigeki Yoshida
    Stephen H. Kennedy
    Kenichi Negoro
    Shinya Hamana
    David H. Barlow
    Takeshi Maruo
    The Journal of the Society for Gynecologic Investigation: JSGI, 2004, 11 : 232 - 236
  • [46] Quantitative DNA perturbations of p53 in endometriosis: analysis of American and Icelandic cases
    Gyfason, JT
    Dang, D
    Petursdottir, V
    Benediktsdottir, KR
    Geirsson, RT
    Poindexter, A
    Mitchell-Leef, D
    Buster, JE
    Carson, SA
    Simpson, JL
    Bischoff, FZ
    FERTILITY AND STERILITY, 2005, 84 (05) : 1388 - 1394
  • [47] P53 Gene as a Promising Biomarker and Potential Target for the Early Diagnosis of Reproductive Cancers
    Aswathi, R. K.
    Arumugam, Suresh
    Muninathan, Natrajan
    Baskar, Kuppusamy
    Deepthi, S.
    Roy, D. Dinesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [48] Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
    Rihani, Ali
    Van Goethem, Alan
    Ongenaert, Mate
    De Brouwer, Sara
    Volders, Pieter-Jan
    Agarwal, Saurabh
    De Preter, Katleen
    Mestdagh, Pieter
    Shohet, Jason
    Speleman, Frank
    Vandesompele, Jo
    Van Maerken, Tom
    SCIENTIFIC REPORTS, 2015, 5
  • [49] Role of p53 alteration in primary peritoneal carcinoma
    Moll, UM
    Valea, F
    Chumas, J
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1997, 16 (02) : 156 - 162
  • [50] Could p53 be a target for therapeutic suppression?
    Komarova, EA
    Gudkov, AV
    SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) : 389 - 400